This poster outlines the provider counselling guide for women of reproductive potential initiating a Dolutegravir-Based Regimen (TLD). Refer to the following: National Consolidated Guidelines for the Management of HIV in Adults, Adolescents, Children and Infants and Prevention of Mother-to-Child Transmission The 2019 ART Clinical Guidelines for the Management of HIV in Adults, Pregnancy, Adolescents, Children, Infants, and Neonates Guideline for the Prevention of Mother to Child Transmission of Communicable Infections The Standard Operating Procedures: CCMDD: Tenofovir & Lamivudine & Dolutegravir (TLD) - Patient Registration or Transition Standard Operating Procedure